The shareholders at their AGM held on September 3, 2026 approved the re-appointment of Mr. S. Madhavan as Independent Director of the Company for a period of 5 years effective November 15, 2026.

September 4, 2026 To, To, The Corporate Relations Department The Listing Department The BSE Limited The National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001. Mumbai – 400051 Ref:- Scrip Code:- 500126 Ref:- Symbol:- PGHL Dear Sir / Madam, Sub: Re-appointment of Mr. S. Madhavan as Independent Director of the Company, for a period of five years, with effect from November 15, 2026 This is in reference to our letter dated May 26, 2026, regarding re-appointment of Mr. S. Madhavan as Independent Director of the Company, for a period of five years, with effect from November 15, 2026, subject to the approval of the shareholders of the Company. We are pleased to inform you that the re-appointment of Mr. S. Madhavan as Independent Director of the Company has been approved by the shareholders of the Company at its 59th Annual General Meeting (“AGM”) held on September 3, 2026. We request you to kindly take the above information on record. Thanking you, Yours faithfully, For Procter & Gamble Health Limited Flavia Machado Authorised Signatory